Post Market, Prospective Multicenter Observational Study of the Safety and Performance of Bellavista Ventilator

NCT ID: NCT05383651

Last Updated: 2024-09-05

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

350 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-01

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This prospective post market clinical follow up (PMCF) study will evaluate the safety and performance of bellavista ventilator and the iFlow sensors in daily clinical routine.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective, multicenter, single-cohort post market observational study, which will analyze data from neonatal, pediatric and adult patients, who are ventilated with the bellavista ventilator.

Ventilator data are continuously recorded in the bellavista ventilator. Patient related data will be recorded in an electronic case report form (CRF). Data from the ventilator and the eCRF are then combined and the primary and secondary endpoints calculated.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ventilation Therapy; Complications

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adults

bellavista 1000

Intervention Type DEVICE

observational use of Bellavista 1000 ventilator in adult ventilated patients

Pediatric/ Neonates

bellavista 1000 neo

Intervention Type DEVICE

observational use of Bellavista 1000 ventilator in neonatal ventilated patients

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bellavista 1000

observational use of Bellavista 1000 ventilator in adult ventilated patients

Intervention Type DEVICE

bellavista 1000 neo

observational use of Bellavista 1000 ventilator in neonatal ventilated patients

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient ventilated with bellavista
* Patient in ICU setting
* Signed informed consent per ethical committee requirements

Exclusion Criteria

* Patients expected to be ventilated less than 12 hours
* The clinical care team does not agree with inclusion of the patient to the study
Minimum Eligible Age

6 Months

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vyaire Medical

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Health Network

Toronto, Ontario, Canada

Site Status

University Children's Hospital Zürich

Zurich, Canton of Zurich, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

100-P0243

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

VAP Identification by AI
NCT06917521 COMPLETED